Dr. Saadia Nawal, MD

Dr. Nawal practices at Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare.

Dr. Nawal's NPI, 1396364873, was assigned on April 14, 2020. Dr. Nawal graduated from George Washington University School of Medicine in 2020. Dr. Nawal holds Minnesota license 74934.

Dr. Nawal's primary practice is Mary Washington Hospital, at 1001 Sam Perry Boulevard, Fredericksburg, VA 22401 in Fredericksburg City. The practice phone is (540) 741-1100.

Dr. Nawal's primary practice is Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare. Dr. Nawal is also affiliated with Inova Fairfax Hospital. The medical group on file is Mary Washington Healthcare. Dmand AI also links Dr. Nawal to 4 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nawal practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Nawal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Nawal's licenses on file in 2 states: Minnesota and Virginia.

CMS data shows 317 Medicare services from Dr. Nawal across 4 procedure codes in 2024, for 129 Medicare patients. Medicare paid $21,489 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Nawal in 2024. The largest group is under 65, with 38 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nawal's median patient age at 73, with 56% women.

In 2024, Dr. Nawal wrote 307 Medicare Part D claims for 99 patients. 84% of them were for generic drugs. CMS names the drug for 86 of them, across 6 drugs with 11 or more claims each, at $14,929 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Nawal for performance year 2024, reported as part of a group. Dr. Nawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Nawal, published from 2016 to 2021. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Nawal has published most often in QJM. Dr. Nawal's most frequent co-authors are Anjan Trikha, MD, Marie Leslie Borum, MD and Wonseok William Choi.

CMS Open Payments shows 4 general payments to Dr. Nawal from 4 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Solta Medical, a division of Bausch Health US, LLC paid the most, $126.

Dr. Nawal graduated from George Washington University School of Medicine in 2020.